S
SCYX
Scynexis
1.000
+0.008+0.81%After Hours: 1.010 +0.010 +1.00%19:43 04/10 EDT
OPEN/PREV CLOSE1.010/0.9920
TODAY RANGE0.9600-1.050
VOL606.51K
MARKET CAP44.66M
52 WEEK RANGE0.5650-1.310
AVG VOL (3M)596.92K
% TURNOVER1.36%
TURNOVER--
P/E (TTM)-5.8005
% RANGE8.97%
EPS(TTM)-0.1724
P/E(FORWARD)-1.8182
P/B0.8818
BVPS1.134
DIVIDEND--
P/S2.114
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP43.00M
SHARES OUTSTANDING44.66M
NEXT EARNINGS05/13-05/18
FREE FLOAT43.00M
LOT SIZE1
EX-DATE07/17/2020
News
Press Releases
Financial Reports
Profile
Reuters·04/02 12:02
SCYNEXIS CEO David Angulo Gonzalez buys common shares for $0.1 million
Seeking Alpha·04/01 14:04
ISM Manufacturing unexpectedly rises in March
TipRanks·03/31 23:54
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
Reuters·03/31 21:29
SCYNEXIS completes acquisition of Poxel’s PXL-770 for ADPKD treatment
Reuters·03/31 21:06
Poxel sells PXL770 to Scynexis for up to $200 million
TipRanks·03/31 14:49
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
TipRanks·03/31 14:46
SCYNEXIS Raises $40 Million in Strategic Private Placement
NASDAQ·03/31 11:42
Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up
TipRanks·03/31 11:20
Poxel announces sale of PXL770 to Scynexis for up to $196M
Benzinga·03/31 10:51
SCYNEXIS Announces $40M Private Placement, Warrants May Add $52M To Proceeds
TipRanks·03/31 10:50
Scynexis completes acquisition of PXL-770 for treatment of kidney disease
TipRanks·03/31 10:50
Scynexis announces $40M private placement
Reuters·03/31 10:45
SCYNEXIS ANNOUNCES $40.0 MILLION PRIVATE PLACEMENT
Reuters·03/31 10:45
SCYNEXIS INC - ESTIMATES FUNDS WILL SUPPORT OPERATIONS INTO MID-2029
Dow Jones·03/31 10:45
Press Release: SCYNEXIS Announces $40.0 Million Private Placement